Qingdao Haier Biomedical Co., Ltd. announced that from August 14, 2024, to October 14, 2025, Jiusuo Selected No. 1 has increased its holdings of the company's shares by a total of 15,897,909 shares through centralized bidding and block trading in the secondary market, accounting for 5.00% of the company's total equity. The funds for these additional shares were sourced from its own capital. Following this change in equity, Jiusuo Selected No. 1 has become a shareholder holding over 5% of the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments